DHA for Optimal Health

© 2019 by the authors; CC BY license

bioavailability; EPA; DHA; DPA; metabolic fate; tissue deposition; frequency of intake; EPA and DHA supplementation; n-3 fatty acid; n-6 fatty acid; fatty acid displacement; plasma fatty acid fractions; blood cell fatty acids; pregnancy and nursing; chia oil; erythrocyte phospholipids; ALA and DHA in milk; monocyte chemotactic protein 1; 4-hydroxy hexenal; docosahexaenoic acid; eicosapentaenoic acid; omega-3 long chain polyunsaturated fatty acids (n-3 LCPUFA); recommended intakes; suggested dietary target intakes; omega-3 (n-3) enriched foods; dietary modelling; docosahexaenoic acid; pregnant women; lactating women; plasma; erythrocyte; correlation; arachidonic acid; brain development; brain lipids; diet and dietary lipids; fatty acid/binding protein; docosahexaneoic acid (DHA); eicosapentaenoic acid (EPA); adolescents; cognition; Omega-3 fatty acids; Omega-3 Index; docosahexaenoic acid; brain development; desaturases; psychiatric disorders; n-3 fatty acids; fish oil; Echium oil; stearidonic acid; docosapentaenoic acid; docosahexaenoic acid; eicosapentaenoic acid; cardiac arrhythmia; rat; Ca²⁺; cortical neurons; DHA; LBP; OGD/R; neuroprotection; Trk-B; docosahexaenoic acid; fructose; ER stress; NAFLD; fish; n-3 PUFA; blood pressure; meta-analysis; brain lipids; omega-3 polyunsaturated fatty acids; nutrition; learning; memory; comprehension; development; aging; neurodegeneration; n-3 LCPUFA; dietary intakes; Australian 2011–2012 national nutrition and physical activity survey; recommended n-3 LCPUFA intakes; eicosapentaenoic acid; EPA; docosahexaenoic acid; DHA; long chain n-3 PUFA; genotype; APOE; FADS; docosahexaenoic acid; lactating women; food frequency questionnaire; breast milk; plasma; erythrocyte; correlation